Diphtheria toxin mutant CRM197-mediated transcytosis across blood-brain barrier in vitro

Cellular and Molecular Neurobiology

Volumn 30, Issue 5, 2010, Pages 717-725

  Wang, Ping ^a   Xue, Yixue ^a   Shang, Xiuli ^a   Liu, Yunhui ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Blood brain barrier; Caveolin 1; CRM197; FOXO1A; PI3K Akt

Indexed keywords

CAVEOLIN 1; DIPHTHERIA TOXOID CRM197; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHR;

ARTICLE; BLOOD BRAIN BARRIER; CAVEOLA; CELL LINE; CELL NUCLEUS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG UPTAKE; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TRANSCYTOSIS; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BACTERIAL PROTEINS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; CAVEOLIN 1; CELL LINE; CELL NUCLEUS; ENDOCYTOSIS; FLUORESCENT ANTIBODY TECHNIQUE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SPACE; MODELS, BIOLOGICAL; MUTANT PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; TIME FACTORS;

EID: 77954510224     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-010-9496-x     Document Type: Article

References (41)

1. Abbott NJ, Rönnbäck L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7(1):41-53
2. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-868
3. Buzzi S, Rubboli D, Buzzi G, Buzzi AM, Morisi C, Pironi F (2004) CRM197 (nontoxic diphtheria toxin): effects on advanced cancer patients. Cancer Immunol Immunother 53(11):1041-1048
4. Candela P, Gosselet F, Miller F, Buee-Scherrer V, Torpier G, Cecchelli R, Fenart L (2008) Physiological pathway for lowdensity lipoproteins across the blood-brain barrier: transcytosis through brain capillary endothelial cells in vitro. Endothelium 15 (5-6): 254-264
5. Chang T, Neville DM Jr (1978) Demonstration of diphtheria toxin receptors on surface membranes from both toxin-sensitive and toxin-resistant species. J Biol Chem 253(19):6866-6871
6. Dehouck B, Fenart L, Dehouck MP, Pierce A, Torpier G, Cecchelli R (1997) A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier. J Cell Biol 138(4):877-889
7. Deli MA, Abrahám CS, Kataoka Y, Niwa M (2005) Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. Cell Mol Neurobiol 25(1):59-127
8. Demeule M, Poirier J, Jodoin J, Bertrand Y, Desrosiers RR, Dagenais C, Nguyen T, Lanthier J, Gabathuler R, Kennard M, Jefferies WA, Karkan D, Tsai S, Fenart L, Cecchelli R, Béliveau R (2002) High transcytosis of melanotransferrin (P97) across the blood-brain barrier. J Neurochem 83:924-933
9. Dorland RB, Middlebrook JL, Leppla SH (1979) Receptor-mediated internalization and degradation of diphtheria toxin by monkey kidney cells. J Biol chem 254(22):11337-11342
10. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, Kurzchalia TV (2001) Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293:2449-2452
11. Farquhar M, Palade G (1963) Junctional complexes in various epithelia. J Cell Biol 17:375-412
12. Furuyama T, Nakazawa T, Nakano I, Mori N (2000) Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem J 349:629-634
13. Gaillard PJ, de Boer AG (2006) A novel opportunity for targeted drug delivery to the brain. J Control Release 116(2): e60-e62
14. Gaillard PJ, Brink A, Boer de AG (2004) WO2004069870
15. Gaillard PJ, Brink A, de Boer AG (2005a) Diphtheria toxin receptortargeted brain drug delivery. Int Congres Series 1277:185-198
16. Gaillard PJ, Visser CC, de Boer AG (2005b) Targeted delivery across the blood-brain barrier. Exp Opin Drug Deliv 2(2):299-309
17. Ikezu T, Ueda H, Trapp BD, Nishiyama K, Sha JF, Volonte D, Galbiati F, Byrd AL, Bassell G, Serizawa H, Lane WS, Lisanti MP, Okamoto T (1998) Affinity-purification and characterization of caveolins from the brain: differential expression of caveolin-1,-2, and-3 in brain endothelial and astroglial cell types. Brain Res 804:177-192
18. Jones AR, Shusta EV (2007) Blood-brain barrier transport of therapeutics via receptor-mediation. Pharm Res 24(9):1759-1771
19. Kageyama T, Ohishi M, Miyamoto S, Mizushima H, Iwamoto R, Mekada E (2007) Diphtheria toxin mutant CRM197 possesses weak EF2-ADP-ribosyl activity that potentiates its anti-tumorigenic activity. J Biochem 142:95-104
20. Lee HY, You HJ, Won JY, Youn SW, Cho HJ, Park KW, Park WY, Seo JS, Park YB, Walsh K, Oh BH, Kim HS (2008) Forkhead factor, FOXO3a, induces apoptosis of endothelial cells through activation of matrix metalloproteinases. Arterioscler Thromb Vasc Biol 28:302-308
21. Li S, Couet J, Lisanti MP (1996) Src tyrosine kinases, Gα subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem 271:29182-29190
22. Lu ML, Schneider MC, Zheng YX, Zhang XB, Richie JP (2001) Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem 276(16):13442-13451
23. Majno G, Palade G (1961) Studies on inflammation. 1. The effect of histamine and serotonin on vascular permeability: an electron microscopic study. J Biophys Biochem Cytol 11:571-605
24. Mishima K, Higashiyama S, Asai A, Yamaoka K, Nagashima Y, Taniguchi N, Kitanaka C, Kirino T, Kuchino Y (1998) Heparinbinding epidermal growth factor-like growth factor stimulates mitogenic signaling and is highly expressed in human malignant gliomas. Acta Neuropathol 96(4):322-328
25. Nag S, Venugopalan R, Stewart DJ (2007) Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood-brain barrier breakdown. Acta Neuropathol 114:459-469
26. Predescu D, Palade GE (1993) Plasmalemmal vesicles represent the large pore system of continuous microvascular endothelium. Am J Physiol 265 (2 Pt 2): H725-H733
27. Raab G, Klagsbrun M (1997) Heparin-binding EGF-like growth factor. Biochim Biophys Acta 1333(3):F179-F199
28. Razani B, Lisanti MP (2001) Two distinct caveolin-1 domains mediate the functional interaction of caveolin-1 with protein kinase A. Am J Physiol Cell Physiol 281: C1241-C1250
29. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou H Jr, Kneitz B, Lagaud G, Christ GJ, Edelmann W, Lisanti MP (2001) Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 276:38121-38138
30. Schnitzer JE, Oh P, Pinney E, Allard J (1994) Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J Cell Biol 127(5):1217-1232
31. Sigurdardottir ST, Davidsdottir K, Arason VA, Jonsdottir O, Laudat F, Gruber WC, Jonsdottir I (2008) Safety and immunogenicity of CRM197-conjugated pneumococcal-meningococcal C combination vaccine (9vPnC-MnCC) whether given in two or three primary doses. Vaccine 26:4178-4186
32. Tanaka N, Sasahara M, Ohno M, Higashiyama S, Hayase Y, Shimada M (1999) Heparinbinding epidermal growth factor-like growth factor mRNA expression in neonatal rat brain with hypoxic/ischemic injury. Brain Res 827 (1-2): 130-138
33. Tang ED, Nunez G, Barr FG, Guan KL (1999) Negative regulation of the forkhead transcription factor FKHR by Akt. J Biol Chem 274:16741-16746
34. van den Heuvel AP, Schulze A, Burgering BM (2005) Direct control of caveolin-1 expression by FOXO transcription factors. J Biochem 385:795-802
35. Virgintino D, Robertson D, Errede M, Benagiano V, Tauer U, Roncali L, Bertossi M (2002) Expression of caveolin-1 in human brain microvessels. Neuroscience 115:145-152
36. Visser CC, Stevanović S, Voorwinden LH, Gaillard PJ, Crommelin DJ, Danhof M, De Boer AG (2004) Validation of the transferrin receptor for drug targeting to brain capillary endothelial cells in vitro. J Drug Target 12(3):145-150
37. Wu D, Terrian DM (2002) Regulation of caveolin-1 expression and secretion by a protein kinase cepsilon signaling pathway in human prostate cancer cells. J Biol Chem 277:40449-40455
38. Xia CY, Zhang Z, Xue YX, Wang P, Liu YH (2009) Mechanisms of the increase in the permeability of the blood-tumor barrier obtained by combining low-frequency ultrasound irradiation with small-dose bradykinin. J Neurooncol 94(1):41-50
39. Xie Z, Zeng X, Waldman T, Glazer RI (2003) Transformation of mammary epithelial cells by 3-phosphoinositide-dependent protein kinase-1 activates beta-catenin and c-Myc, and downregulates caveolin-1. Cancer Res 63:5370-5375
40. Yamamoto H, Komekado H, Kikuchi A (2006) Caveolin is necessary for Wnt-3a-dependent internalization of LRP6 and accumulation of b-catenin. Dev Cell 11:213-223
41. Zhao YY, Gao XP, Zhao YD, Mirza MK, Frey RS, Kalinichenko VV, Wang IC, Costa RH, Malik AB (2006) Endothelial cell-restricted disruption of FoxM1 impairs endothelial repair following LPS-induced vascular injury. J Clin Invest 116:2333-2343